Oklo (NYSE:OKLO | OKLO Price Prediction) stock is rallying 14% today to $48.21 after the advanced nuclear developer posted its first meaningful quarterly revenue. Even with today’s pop, Oklo shares remain down 33% year to date (YTD) and sit well below the $193.84 52-week high.
The move caps a volatile stretch for a name that has swung on catalysts more than fundamentals. Getting Oklo stock back to $100 would roughly double it from here, so the question is whether today’s report meaningfully changes the setup.
Revenue Report Sparks the Rally
Oklo reported $1.2 million in Q2 2026 revenue, marking the company’s first material top-line quarter. The company’s quarterly earnings loss came in at $0.28 per share, wider than the roughly $0.16 loss analysts had modeled.
Oklo’s net loss widened to $48.5 million from $24.7 million a year ago as research, development, and operating costs scaled up. Oklo ended the quarter with roughly $3 billion in cash and marketable securities, a runway few pre-commercial advanced nuclear peers can match, and retail sentiment has tilted decisively bullish with a 73.82 average Reddit sentiment score over the past 30 days.
Peers Mixed as Uranium Theme Holds
The broader nuclear and uranium trade is a study in dispersion this year. NuScale Power (NYSE:SMR) stock is down 30% YTD, tracking Oklo’s slide, while Centrus Energy (NYSEAMERICAN:LEU) shares are down 23% despite a strong Q2 earnings report.
Uranium miners have fared much better. Uranium Energy (NYSEAMERICAN:UEC) stock is down 3%, and Energy Fuels shares are down 0.9%. The Global X Uranium ETF (NYSEARCA:URA) is actually up 4% YTD at $44.65, indicating that the underlying nuclear/uranium theme has held up even as several individual names have lagged. The ETF is a concentrated sector fund, so investors should size their positions with that concentration risk in mind.
What It Could Take to Get Oklo Stock Back to $100
A roughly two-fold move for Oklo stock is within its own historical range, but it would likely require several catalysts stacking up. Continued conversion of the company’s project pipeline into contracted revenue, ongoing progress on licensing and regulatory approvals, and evidence that first-of-a-kind deployment is on track could all rebuild the narrative. Momentum from Oklo’s Groves Isotope Test Reactor first criticality milestone may reinforce the operational-progress story that bulls are anchoring to.
Sustained AI data center power demand remains the macro tailwind. The Department of Energy projects that data centers could account for up to 12% of U.S. electrical demand by 2028, and that demand curve is what continues to attract capital toward advanced nuclear names.
The bear case is just as concrete. Oklo remains pre-commercial, cash-burning, and richly valued relative to current revenue. Execution risk on the reactor program is real, non-binding letters of intent are not contracts, and today’s revenue beat comes off a tiny base, with further equity or convertible issuance a risk from the $193.84 peak.
What to Watch Now
Investors can watch for whether Oklo stock’s gains hold into the close, and how management frames the path from first revenue to commercial powerplant deployment on the earnings call. Any signal on licensing progress or new customer conversions could shape the next share-price move.
Beyond the earnings call, key milestones for Oklo include the NRC combined license application progress, first revenue contribution from the Atomic Alchemy radioisotope business, and construction updates at the Aurora powerhouse targeting commercial power by late 2027.
Investors should consider keeping their OKLO stock position sizes modest given the stock’s volatility and pre-commercial status. The path back to $100 is plausible but depends on execution against a stacked catalyst calendar.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks